Unibest

Pipeline Database

UB514

IV Human Immunoglobulin (pH4) for Intravenous Injection

Submit a ProjectNew Drug Candidates DB

UB514

ProductIV Human Immunoglobulin (pH4) for Intravenous Injection
Strength1.25mg, 2.5mg, 5mg
IndicationsX-linked agammaglobulinemia; Common variable immunodeficiency; Immunoglobulin G subclass deficiency; Neonatal sepsis; Idiopathic thrombocytopenic purpura; Kawasaki disease
TherapeuticsImmunology & Inflammation
GMPCN - NMPA
RegistrationChina
ModalitiesProtein

Exclusive Summary

  • Superior Quality Profile: 99.2% purity and 99.3% monomer/dimer content, significantly exceeding national pharmacopeia standards.
  • Enhanced Safety: Extremely low PKA levels (<10 IU/ml) minimize the risk of transfusion-related hypotension, offering a safety advantage over standard competitors.
  • Reliable Supply Chain: Sourced from 21 plasma stations with >1000 donors per batch, ensuring broad antibody diversity and stable supply for global shortages.

Asset Materials

UB514 Asset Materials

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →